Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jun 27;17(6):e86863.
doi: 10.7759/cureus.86863. eCollection 2025 Jun.

A Mysterious Trigger for Serum Amyloid A (SAA)-Associated Amyloidosis: Insights From an Autopsy Study

Affiliations
Case Reports

A Mysterious Trigger for Serum Amyloid A (SAA)-Associated Amyloidosis: Insights From an Autopsy Study

Hem Sunder Thirumurthy et al. Cureus. .

Abstract

Amyloidosis refers to a heterogeneous group of disorders characterized by the extracellular deposition of insoluble fibrillar proteins, leading to tissue damage and functional impairment. Among these, serum amyloid A (SAA) amyloidosis, previously termed secondary amyloidosis, arises in the context of chronic inflammatory conditions. While common causes include autoimmune diseases and chronic infections, the underlying etiology remains unidentified in a subset of cases. We report a rare case of SAA-associated amyloidosis in a 29-year-old male with a history of childhood-onset cystic bronchiectasis. The patient presented with progressive renal dysfunction and was diagnosed with systemic amyloidosis based on histopathological evaluation. Common autoimmune and infectious etiologies were excluded during life. An autopsy revealed alpha-1 antitrypsin deficiency as the underlying cause of chronic pulmonary inflammation, manifesting as cystic bronchiectasis, which likely triggered sustained elevation of serum amyloid A and subsequent amyloid deposition.

Keywords: alpha-1 antitrypsin deficiency; autopsy findings; cystic bronchiectasis; hyaline globules; saa-associated amyloidosis.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Gross and microscopic findings of kidneys.
(A) Gross photograph of the kidneys showing enlargement with nodular capsular surface. (B) Microscopy reveals amorphous, acellular deposits in the mesangium (H&E, 400x). (C) These deposits are congophilic (Congo red, 400x) and show apple-green birefringence under polarized light (D, 100x). (E) Immunohistochemistry reveals strong positivity for serum amyloid A (SAA) protein (400x). (F) Ultrathin electron microscopy shows randomly arranged fibrils measuring 8-12 nm in diameter.
Figure 2
Figure 2. Demonstration of amyloidosis involving different organs.
(A) Microscopy of spleen showing amyloid deposition within the sinusoids, sparing the periarteriolar lymphoid sheath, producing a lardaceous appearance (H&E, 100x). (B) Congo red stain demonstrates apple-green birefringence under polarized light (100x). (C)-(F) Similar congophilic amyloid deposits are observed in the hepatic artery, portal vein, small intestine, pituitary, and bone marrow (Congo red, 100x).
Figure 3
Figure 3. Gross and microphotographs of lung and liver.
(A) Gross photograph of both lungs showing bronchiectasis. (B) Spongy emphysematous changes involving the lower lobes. (C) Microscopy reveals panacinar emphysema (H&E, 100x). (D) Higher magnification shows ruptured and floating interalveolar septa (H&E, 400x). (E) Microscopy of the liver showing ground-glass-like globules in periportal hepatocytes (H&E, 400x). (F) PAS stain highlights hyaline globules in periportal hepatocytes (PAS, 400x). (G) These globules are resistant to diastase digestion (PAS-D, 400x). (H) Immunostaining for alpha-1 antitrypsin shows strong positivity in the hyaline globules (DAB chromogen, 400x). PAS-D: periodic acid-Schiff with diastase, DAB: 3,3'-Diaminobenzidine.

Similar articles

References

    1. Molecular mechanisms of amyloidosis. Merlini G, Bellotti V. N Engl J Med. 2003;349:583–596. - PubMed
    1. Natural history and outcome in systemic AA amyloidosis. Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN. N Engl J Med. 2007;356:2361–2371. - PubMed
    1. Secondary, AA, amyloidosis. Papa R, Lachmann HJ. Rheum Dis Clin North Am. 2018;44:585–603. - PubMed
    1. Amyloidosis and acute phase proteins. Husby G. Scand J Rheumatol. 1982;11:201–207.
    1. Revised nomenclature for serum amyloid A (SAA), part 2. Sipe J. J Immunol. 1999;162:2063–2064. - PubMed

Publication types

LinkOut - more resources